Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 1

Figure 1


Figure 1 Cumulative Kaplan-Meier event rates (fatal and non-fatal) in the three treatment groups in the Valsartan in Acute Myocardial Infarction Trial (VALIANT). The p values are for comparisons with captopril and are based on log-rank tests. Black line = captopril; blue line = valsartan; orange line = combination.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement